Baralgin in ampoules

Baralgin in ampoules is considered a strong enough drug. According to reviews of some patients, the medication is effective within fifteen to thirty minutes.

Baralgin (injections) is an NSAID derivativepyrazolone. The mechanism of action of the drug practically does not differ from other nonsteroidal anti-inflammatory drugs. Baralgin in ampoules is able to prevent pain impulses, increase the threshold of excitability in thalamic centers of pain sensitivity, and increase heat transfer. The peculiarity of the medication is a slight anti-inflammatory effect. Baralgin in ampoules has antipyretic, analgesic and pronounced spasmolytic (on smooth muscles in the biliary and urinary tracts) effect.

The medicine is shown at a feverish syndrome (onbackground of insect bites, infectious and inflammatory diseases, posttransfusion complications). Baralgin in ampoules is prescribed to eliminate pain of moderate and mild character. Indications include biliary colic, myalgia, neuralgia, burns, arthralgia, trauma, decompression sickness, sciatica, shingles, postoperative syndrome (pain), algodismenorea, dental, headache and others.

The solution is administered intravenously or intramuscularlythree times a day for adults 250-500 mg. The dosage of the drug "Baralgin" (in ampoules) instruction allows for one injection not more than 1 gram, per day - no more than two grams.

For patients up to one year, the drug is administered only intramuscularly. The temperature of the solution for injection should be the same as that of the patient's body.

With intravenous administration, it is necessary to providecarrying out anti-shock therapy. The most common reason for reducing (sharp) blood pressure is an increased injection rate. In this regard, intravenous administration is slow, with the patient lying down.

The use of the drug causes in some patientsanuria, oliguria, a disorder of kidney function, interstitial nephritis, a change in the color of urine, proteinuria. There are also allergic manifestations (Quincke's edema, hives on the skin and mucous nasopharynx and conjunctiva). In rare cases, there was exudative erythema (malignant), anaphylactic shock, bronchospastic syndrome. The use of medication can provoke thrombocytopenia, lowering blood pressure, agranulocytosis. Infiltrates are likely at the site of administration.

Overdose is characterized by vomiting, nausea,hypothermia, lowering blood pressure, oliguria, gastralgia, dyspnea, tinnitus, delirium, drowsiness, hemorrhagic syndrome, consciousness disorder, convulsions, development of renal, hepatic insufficiency (acute), paralysis in respiratory muscles. When these symptoms occur, they provoke vomiting, and the stomach is washed (through the probe). Assign salt laxatives, charcoal activated, symptomatic treatment.

Baralgin contraindicated in oppressionhemopoiesis, hereditary hemolytic anemia, hypersensitivity, lactation, liver failure, kidney failure, leukopenia, anemia, pregnancy. With special care, the drug is prescribed in infancy (up to three months).

In the treatment of children under five years of age who are shown cytostatic agents, the intake of metamizole sodium (the active component of Baralgina) is carried out under the constant supervision of a specialist.

During pregnancy, any NSAIDs are not recommended.

Before use, you should carefully study the annotation, consult a doctor, find out all the alleged side effects from the use of the drug.